Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes
- 9 April 2003
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 70 (2) , 301-308
- https://doi.org/10.1002/jmv.10395
Abstract
Development of subunit vaccines against respiratory syncytial virus (RSV) for naive human infants is hindered by concerns that immunization with the fusion or attachment (G) proteins will elicit polarized Type 2 T cell responses and cause immunopotentiation upon subsequent natural infection. We investigated the regions of G protein responsible for inducing a Type 2 T cell phenotype in inbred mice of different MHC haplotype toward development of vaccines with improved safety. As demonstrated by IL-5-dependent pulmonary eosinophilia after challenge and serum anti-G protein IgG1 to IgG2 ratios, highly purified native G protein sensitized all strains for a Type 2 T cell phenotype. Stimulation of G protein-primed splenocytes with synthetic overlapping peptides indicated that the nonglycosylated ectodomain was primarily responsible. Respectively the recall responses of BALB/c (H2d), C57BL/6 (H-2b), SJL (H-2s), and C3H/HeJ (H-2k) mice were directed against epitopes within peptides spanning amino acids 184–198 (pep184–198), 168–181 (pep168–181) or 171–185 (pep171–185), 176–190 (pep176–190), and 104–118 (pep104–118) or 159–173 (pep159–173). Injection of pep184–198 conjugated to KLH (pep184–198-KLH) primed H2d [BALB/c, B6.C-H2d/bBy], but not H-2b [C57Bl/6, C.B10-H2b/LiMcd] mice for pulmonary eosinophilia. Sensitization with a peptide-KLH conjugate encompassing amino acids 149–200 (pep149–200-KLH) further confirmed that Type 2 T cell responses in BALB/c, C57BL/6 and SJL, but not C3H/HeJ mice were induced by the nonglycosylated ectodomain of G protein. These data are important for design of safe and efficacious subunit and attenuated vaccines for RSV. J. Med. Virol. 70: 301–308, 2003.Keywords
This publication has 34 references indexed in Scilit:
- Adaptive Immune Responses of Patients with Asthma to the Attachment (G) Glycoprotein of Respiratory Syncytial VirusThe Journal of Infectious Diseases, 2001
- Expression of Respiratory Syncytial Virus-Induced Chemokine Gene Networks in Lower Airway Epithelial Cells Revealed by cDNA MicroarraysJournal of Virology, 2001
- Serum Neutralizing Antibody Titers of Seropositive Chimpanzees Immunized with Vaccines Coformulated with Natural Fusion and Attachment Proteins of Respiratory Syncytial VirusThe Journal of Infectious Diseases, 2000
- Respiratory Syncytial Virus Pneumonia among the Elderly: An Assessment of Disease BurdenThe Journal of Infectious Diseases, 1999
- NONSEGMENTED NEGATIVE-STRAND RNA VIRUSES: Genetics and Manipulation of Viral GenomesAnnual Review of Genetics, 1998
- Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometryProtein Science, 1997
- Increase in CD23+ B Cells in Infants with Bronchiolitis Is Accompanied by Appearance of IgE and IgG4 Antibodies Specific for Respiratory Syncytial VirusThe Journal of Infectious Diseases, 1997
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in mice that are similar to those generated by experimental infectionVaccine, 1995
- Lymphokine Control of In Vivo Immunoglobulin Isotype SelectionAnnual Review of Immunology, 1990